Post-exercise Branched Chain Amino Acid Supplementation Does Not Affect Recovery Markers Following Three Consecutive High Intensity Resistance Training Bouts Compared to Carbohydrate Supplementation
Overview
Authors
Affiliations
Background: Amino acid supplementation has been shown to potentially reduced exercise-induced muscle soreness. Thus, the purpose of this study was to examine if branched chain amino acid and carbohydrate (BCAACHO) versus carbohydrate-only sports drink (CHO) supplementation attenuated markers of muscle damage while preserving performance markers following 3 days of intense weight training.
Methods: Healthy resistance-trained males (n = 30) performed preliminary testing (T1) whereby they: 1) donated a baseline blood draw, 2) performed knee extensor dynamometry to obtain peak quadriceps isometric and isokinetic torque as well as electromyography (EMG) activity at 60°/s and 120°/s, and 3) performed a one repetition maximum (1RM) barbell back squat. The following week participants performed 10 sets x 5 repetitions at 80 % of their 1RM barbell back squat for 3 consecutive days and 48 h following the third lifting bout participants returned for (T2) testing whereby they repeated the T1 battery. Immediately following and 24 h after the three lifting bouts, participants were randomly assigned to consume one of two commercial products in 600 mL of tap water: 1) BCAAs and CHO (3 g/d L-leucine, 1 g/d L-isoleucine and 2 g/d L-valine with 2 g of CHO; n = 15), or 2) 42 g of CHO only (n = 15). Additionally, venous blood was drawn 24 h following the first and second lifting bouts and 48 h following the third bout to assess serum myoglobin concentrations, and a visual analog scale was utilized prior, during, and after the 3-d protocol to measure subjective perceptions of muscular soreness.
Results: There were similar decrements in 1RM squat strength and isokinetic peak torque measures in the BCAA-CHO and CHO groups. Serum myoglobin concentrations (p = 0.027) and perceived muscle soreness (p < 0.001) increased over the intervention regardless of supplementation. A group*time interaction was observed for monocyte percentages (p = 0.01) whereby BCAA-CHO supplementation attenuated increases in this variable over the duration of the protocol compared to CHO supplementation.
Conclusion: BCAA-CHO supplementation did not reduce decrements in lower body strength or improve select markers of muscle damage/soreness compared to CHO supplementation over three consecutive days of intense lower-body training.
Zhang X, Li L, Tu Y, Zhang L, Shang H, Liu M Front Nutr. 2025; 11():1463202.
PMID: 39845911 PMC: 11750653. DOI: 10.3389/fnut.2024.1463202.
Vicario-Merino A, Soriano M, Jimenez-Ormeno E, Ruiz-Moreno C, Gallo-Salazar C, Areces-Corcuera F Healthcare (Basel). 2024; 12(8).
PMID: 38667628 PMC: 11050702. DOI: 10.3390/healthcare12080866.
Weber M, Dias S, de Angelis T, Fernandes E, Bernardes A, Milanez V Amino Acids. 2021; 53(11):1663-1678.
PMID: 34669012 DOI: 10.1007/s00726-021-03089-2.
Khemtong C, Kuo C, Chen C, Jaime S, Condello G Nutrients. 2021; 13(6).
PMID: 34072718 PMC: 8230327. DOI: 10.3390/nu13061880.
Holecek M Metabolites. 2020; 10(8).
PMID: 32784821 PMC: 7464849. DOI: 10.3390/metabo10080324.